Head and Neck Pathology

, Volume 9, Issue 1, pp 6–15 | Cite as

Approach to Metastatic Carcinoma of Unknown Primary in the Head and Neck: Squamous Cell Carcinoma and Beyond

Proceedings of the North American Society of Head and Neck Pathology Companion Meeting, March 22, 2015, Boston, Massachusetts

Abstract

Metastatic carcinoma to cervical lymph nodes presenting as an unknown primary is quite common. In most cases, the primary site is ultimately identified. Carcinomas that remain of unknown primary after a thorough search are uncommon. This review will focus on those cases that initially present as unknown primaries, since this is the setting in which pathologists first encounter these cases and in which they play an important role in guiding patient management. Most are squamous cell carcinomas, the majority of which are human papillomavirus (HPV)-related and originate in the palatine tonsils and base of tongue. HPV-related oropharyngeal squamous cell carcinomas are increasing in incidence and have unique clinical and pathologic features that make them particularly likely to present as an unknown primary. Understanding these features has led to improved detection of the primary tumors. Further, even when the primary tumor is not found, prognosis is very dependent on characterization of the tumor HPV status. Papillary thyroid carcinomas may also initially present without a known or clinically detectable primary, either as a neck mass or incidentally in a neck dissection performed for another indication. The latter is a very indolent disease. Finally, primary salivary gland carcinomas may mimic an unknown primary and need to be distinguished from cutaneous metastases to the parotid gland, which may present without a recognized skin tumor. Here, we review the clinical and pathologic features of these entities and provide a systematic approach to their diagnosis.

Keywords

Carcinoma of unknown primary Squamous cell carcinoma Head and neck Human papillomavirus Thyroid Salivary 

Notes

Conflict of interest

The authors have no conflicts of interest or funding to disclose.

References

  1. 1.
    Pavlidis N, Briasoulis E, Hainsworth J, Greco F. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer. 2003;39(14):1990–2005.CrossRefPubMedGoogle Scholar
  2. 2.
    Guntinas-Lichius O, Klussman J, Dinh S, Dinh M, Schmidt M, Semrau R, et al. Diagnostic work-up and outcome of cervical metastases from an unknown primary. Acta Otolaryngol. 2006;126(5):536–44.CrossRefPubMedGoogle Scholar
  3. 3.
    Cervin J, Silverman J, Loggie B, Geisinger K. Virchow’s node revisted. Analysis with clinicopathologic correlation of 152 fine-needle aspiration biopsies of supraclavicular lymph nodes. Arch Pathol Lab Med. 1995;119:727–30.PubMedGoogle Scholar
  4. 4.
    Cianchetti M, Mancuso A, Amdur R, Werning J, Kirwan J, Morris C, et al. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope. 2009;119(12):2348–54.CrossRefPubMedGoogle Scholar
  5. 5.
    Zengel P, Assmann G, Mollenhauer M, Jung A, Sotlar K, Kirchner T, et al. Cancer of unknown primary originating from oropharyngeal carcinomas are strongly correlated to HPV positivity. Vichows Arch. 2012;461(3):283–90.CrossRefGoogle Scholar
  6. 6.
    Tribius S, Hoffmann A, Bastrop S, Gorogh T, Haaq J, Rocken C, et al. HPV status in patients with head and neck of carcinoma of unknown primary site: HPV, tobacco smoking, and outcome. Oral Oncol. 2012;48(11):1178–84.CrossRefPubMedGoogle Scholar
  7. 7.
    Compton A, Moore-Medlin T, Herman-Ferdinandez L, Clark C, Caldito G, Wang X, et al. Human papillomavirus in metastatic lymph nodes from unknown primary head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg. 2011;145(1):51–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Chaturvedi A, Engels E, Pfeiffer R, Hernandez B, Xiao W, Kim E et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294–301.Google Scholar
  9. 9.
    Lewis J Jr, Thorstad W, Chernock R, Haughey B, Yip J, Zhang Q, et al. p16 positive oropharyngeal squamous cell carcinoma: an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol. 2010;34:1088–96.CrossRefPubMedGoogle Scholar
  10. 10.
    Weiss D, Koopman M, Rudack C. Prevalence and impact on clinicopathological characteristics of human papillomavirus-16 DNA in cervical lymph node metastases of head and neck squamous cell carcinoma. Head Neck. 2011;33(6):856–62.CrossRefPubMedGoogle Scholar
  11. 11.
    Ang K, Harris J, Wheeler R, Weber R, Rosenthal D, Nguyen-Tan P, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24–35.CrossRefPubMedCentralPubMedGoogle Scholar
  12. 12.
    Perry M. The specialised structure of crypt epithelium in the human palatine tonsil and its functional significance. J Anat. 1994;185(1):111–27.PubMedCentralPubMedGoogle Scholar
  13. 13.
    Chernock R, Lewis J Jr, Zhang Q, El-Mofty S. Human papillomavirus-positive basaloid squamous cell carcinomas of the upper aerodigestive tract: a distinct clinicopathologic and molecular subtype of basaloid squamous cell carcinoma. Hum Pathol. 2010;41(7):1016–23.CrossRefPubMedGoogle Scholar
  14. 14.
    Goldenberg D, Begum S, Westra W, Khan Z, Sciubba J, Pai S, et al. Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck. 2008;30(7):898–903.CrossRefPubMedGoogle Scholar
  15. 15.
    Maxwell J, Kumar B, Feng F, McHugh J, Cordell K, Eisbruch A, et al. HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans. Head Neck. 2010;32(5):562–7.PubMedCentralPubMedGoogle Scholar
  16. 16.
    Nakao K, Yuge T, Mochiki M, Nibu K, Sugasawa M. Detectionj of Epstein-Barr virus in metastatic lymph nodes of patients with nasopharyngeal carcinoma and a primary unknown carcinoma. Arch Otolaryngol Head Neck Surg. 2003;129(3):338–40.CrossRefPubMedGoogle Scholar
  17. 17.
    Regauer S, Gogg-Kamerer M, Braun H, Beham A. Lateral neck cysts–the branchial theory revisited. A critical review and clinicopathological study of 97 cases with special emphasis on cytokeratin expression. APMIS. 1997;105(8):623–30.CrossRefPubMedGoogle Scholar
  18. 18.
    Pai R, Erikson J, Pourmand N, Kong C. p16(INK4A) immunohistochemical staining may be helpful in distinguishing branchial cleft cysts from cystic squamous cell carcinomas originating in the oropharynx. Cancer Cytopathol. 2009;117(2):108–19.CrossRefGoogle Scholar
  19. 19.
    Vent J, Haidle B, Wedemeyer I, Huebbers C, Siefer O, Semrau R, et al. p16 expression in carcinoma of unknown primary: diagnostic indicator and prognostic marker. Head Neck. 2013;35(11):1521–6.CrossRefPubMedGoogle Scholar
  20. 20.
    Lewis J Jr. p16 immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma. Head Neck Pathol. 2012;6(Suppl 1):S75–82.CrossRefPubMedGoogle Scholar
  21. 21.
    Chernock R, Wang X, Gao G, Lewis J Jr, Zhang Q, Thorstad W, et al. Detection and significance of human papillomavirus, CDKN2A(p16) and CDKN1A(p21) expression in squamous cell carcinoma of the larynx. Mod Pathol. 2013;26(2):223–31.CrossRefPubMedCentralPubMedGoogle Scholar
  22. 22.
    Beadle B, William W Jr, McLemore M, Sturgis E, Williams M. p16 expression in cutaneous squamous cell carcinomas with neck metastases: a potential pitfall in identifying unknown primaries of the head and neck. Head Neck. 2013;35(11):1527–33.CrossRefPubMedGoogle Scholar
  23. 23.
    Zhang M, El-Mofty S, Davila R. Detection of human papillomavirus-related squamous cell carcinoma cytologically and by in situ hybridization in fine-needle aspiration biopsies of cervical metastasis: a tool for identifying the site of an occult head and neck primary. Cancer Cytopathol. 2008;114(2):118–23.CrossRefGoogle Scholar
  24. 24.
    Smith D, Maleki Z, Coughlan D, Gooi Z, Akpeng B, Ogawa T, et al. Human papillomavirus status of head and neck cancer as determined in cytologic specimens using the hybrid-capture 2 assay. Oral Oncol. 2014;50(6):600–4.CrossRefPubMedCentralPubMedGoogle Scholar
  25. 25.
    Keller F, Psychogios G, Linke R, Lell M, Kuwert T, Iro H, et al. Carcinoma of unknown primary in the head and neck: comparison between positron emission tomography (PET) and PET/CT. Head Neck. 2011;33(11):1569–75.CrossRefPubMedGoogle Scholar
  26. 26.
    Karni R, Rich J, Sinha P, Haughey B. Transoral laser microsurgery: a new approach for unknown primaries of the head and neck. Laryngoscope. 2011;121(6):1194–201.CrossRefPubMedGoogle Scholar
  27. 27.
    Durmas K, Rangarajan S, Old M, Agrawal A, Teknos T, Ozer E. Transoral robotic approach to carcinoma of unknown primary. Head Neck. 2014;36(6):848–52.CrossRefGoogle Scholar
  28. 28.
    Koch W, Bhatti N, Williams M, Eisele D. Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source. Otolaryngol Head Neck Surg. 2001;124:331–3.CrossRefPubMedGoogle Scholar
  29. 29.
    Davis K, Byrd J, Mehta V, Chiosea S, Kim S, Ferris R, et al. Occult primary head and neck squamous cell carcinoma: utility of discovering primary lesions. Otolaryngol Head Neck Surg. 2014;151(2):272–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Garrel R, Tripodi C, Cartier C, Makeieff M, Crampette L, Guerrier B. Cervical lymphadenopathies signaling thyroid microcarcinoma. Case study and review of the literature. Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128:115–9.CrossRefPubMedGoogle Scholar
  31. 31.
    Harach H, Franssila K, Wasenius V. Occult papillary carcinoma of the thyroid. A “normal” finding in Fibland. A systematic autopsy study. Cancer. 1985;56(3):531–8.CrossRefPubMedGoogle Scholar
  32. 32.
    Leon X, Sancho F, Garcia J, Sanudo J, Orus C, Quer M. Incidence and significance of clinically unsuspected thyroid tissue in lymph nodes found during neck dissection in head and neck carcinoma patients. Laryngoscope. 2005;115(3):470–4.CrossRefPubMedGoogle Scholar
  33. 33.
    Kessler A, Rappaport Y, Blank A, Marmor S, Weiss J, Graif M. Cystic appearance of cervical lymph nodes is characteristic of metastatic papillary thyroid carcinoma. J Clin Ultrasound. 2003;31(1):21–5.CrossRefPubMedGoogle Scholar
  34. 34.
    Michal M, Kacerovska D, Kazakov D. Cribriform adenocarcinoma of the tongue and minor salivary glands: a review. Head Neck Pathol. 2013;7(Suppl 1):S3–11.CrossRefPubMedGoogle Scholar
  35. 35.
    Daniel E, McGuirt W Sr. Neck masses secondary to heterotopic salivary gland tissue: a 25-year experience. Am J Otolaryngol. 2005;26(2):96–100.CrossRefPubMedGoogle Scholar
  36. 36.
    Bron L, Traynor S, McNeil E, O’Brien C. Primary and metastatic cancer of the parotid: comparison of clinical behavior in 232 cases. Laryngoscope. 2003;113(6):1070–5.CrossRefPubMedGoogle Scholar
  37. 37.
    Chen M, Roman S, Sosa J, Judson B. Prognostic factors for squamous cell cancer of the parotid gland: an analysis of 2104 patients. Head Nack. 2013;Epub ahead of print.Google Scholar
  38. 38.
    Chernock R, Duncavage E, Gnepp D, El-Mofty S, Lewis J Jr. Absence of Merkel cell polyomavirus in primary parotid high-grade neuroendocrine carcinomas regardless of cytokeratin 20 immunophenotype. Am J Surg Pathol. 2011;35(12):1806–11.CrossRefPubMedGoogle Scholar
  39. 39.
    Feng H, Shuda M, Chang Y, Moore P. Clonal integration of a polypomavirus in human Merkel cell carcinoma. Science. 2008;319(5866):1096–100.CrossRefPubMedCentralPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of Pathology and ImmunologyWashington University School of MedicineSt. LouisUSA
  2. 2.Department of Otolaryngology Head and Neck SurgeryWashington University School of MedicineSt. LouisUSA

Personalised recommendations